Aquestive Therapeutics, Inc. (AQST)

USD 3.0

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 57.41 Million 55.67 Million 61.99 Million 62.88 Million 78.47 Million 86.85 Million
Total Current Assets 40.96 Million 39.88 Million 47.25 Million 44.62 Million 68.31 Million 74.2 Million
Cash And Short Term Investments 23.87 Million 27.27 Million 28.02 Million 31.8 Million 49.32 Million 60.59 Million
Cash and Cash Equivalents 23.87 Million 27.27 Million 28.02 Million 31.8 Million 49.32 Million 60.59 Million
Short Term Investments - - - - - -
Net Receivables 8.47 Million 4.7 Million 12.12 Million 6.95 Million 13.13 Million 6.48 Million
Inventory 6.76 Million 5.78 Million 4.03 Million 2.46 Million 2.85 Million 5.44 Million
Other Current Assets 1.85 Million 2.13 Million 3.07 Million 3.4 Million 2.99 Million 1.68 Million
Total Non-Current Assets 16.45 Million 15.78 Million 14.73 Million 18.25 Million 10.16 Million 12.65 Million
Net PPE 9.73 Million 7.9 Million 7.78 Million 10.32 Million 9.72 Million 12.2 Million
Good Will And Intangible Assets 1.27 Million 1.43 Million 51 Thousand 102 Thousand 439 Thousand 204 Thousand
Good Will - - - - 286 Thousand -
Intangible Assets 1.27 Million 1.43 Million 51 Thousand 102 Thousand 153 Thousand 204 Thousand
Long-Term Investments 4 Million 5 Million 6 Million 7 Million - -
Tax Assets -1.00 -5 Million -6 Million -7 Million - -
Other Non Current Assets 1.43 Million 6.45 Million 6.9 Million 7.83 Million - 239 Thousand
Other Assets 1.00 - - - - -
Total Liabilities 163.9 Million 174.22 Million 144.12 Million 111.38 Million 84.6 Million 76.77 Million
Total Current Liabilities 18.3 Million 39.67 Million 21.96 Million 21.1 Million 18.55 Million 32.95 Million
Account Payables 8.92 Million 9.94 Million 8.31 Million 7.08 Million 12.27 Million 20.43 Million
Tax Payables 337 Thousand 322 Thousand 349 Thousand 316 Thousand 300 Thousand 2.9 Million
Short Term Debt 2.34 Million 19.1 Million 2.92 Million 3.3 Million - 4.6 Million
Deferred Revenue 1.55 Million 1.51 Million 765 Thousand 693 Thousand 806 Thousand 721 Thousand
Other Current Liabilities 5.48 Million 9.11 Million 9.96 Million 10.01 Million 5.47 Million 7.19 Million
Total Non Current Liabilities 145.59 Million 134.55 Million 122.16 Million 90.27 Million 66.04 Million 43.81 Million
Long-Term Debt 91.07 Million 36.98 Million 53.49 Million 37.17 Million 60.33 Million 42.6 Million
Deferred Revenue Non Current 32.34 Million 31.41 Million 7.12 Million 3.63 Million 4.34 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 16.77 Million 66.14 Million 2.48 Million 1.94 Million 1.36 Million 1.21 Million
Other Liabilities - - - - - -
Total Equity -106.48 Million -118.55 Million -82.13 Million -48.49 Million -6.12 Million 10.08 Million
Stock Holders Equity -106.48 Million -118.55 Million -82.13 Million -48.49 Million -6.12 Million 10.08 Million
Common Stock 69 Thousand 55 Thousand 41 Thousand 35 Thousand 34 Thousand 25 Thousand
Retained Earnings -319.07 Million -311.2 Million -256.79 Million -186.25 Million -130.47 Million -61.37 Million
Accumulated other comprehensive income - - - - - -35.19 Million
Common Stock Equity -106.48 Million -118.55 Million -82.13 Million -48.49 Million -6.12 Million 10.08 Million
Capital Lease Obligation 5.39 Million 3.94 Million 2.84 Million 3.57 Million - -
Total Investments 4 Million 5 Million 6 Million 7 Million - -
Total Debt 98.82 Million 56.09 Million 56.42 Million 40.47 Million 60.33 Million 47.2 Million
Net Debt 74.95 Million 28.82 Million 28.39 Million 8.67 Million 11.01 Million -13.39 Million

Balance Sheet Charts